Prostaglandin E2 inhibits T cell activation-induced apoptosis and Fas-mediated cellular cytotoxicity by blockade of Fas-ligand induction

被引:0
作者
Porter, BO [1 ]
Malek, TR [1 ]
机构
[1] Univ Miami, Sch Med, Dept Microbiol & Immunol, Miami, FL 33101 USA
关键词
prostaglandin E-2; apoptosis; activation-induced cell death; Fas ligand; T cell;
D O I
10.1002/(SICI)1521-4141(199907)29:07<2360::AID-IMMU2360>3.0.CO;2-A
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Prostanoids exhibit both pro-apoptotic and anti-apoptotic functions depending on the maturation stage and tissue localization of target cells. Prostaglandin (PG) E-2 has been shown to protect T lymphocytes from TCR-mediated activation-induced cell death, but the mechanism by which PGE(2) inhibits apoptosis of T cells has not been established. We show that this protection involves the down-regulation of Fas-ligand (Fas-L) mRNA levels in T cells. Modulation of cell surface Fas-L expressin by physiological concentrations of PGE(2) was shown to be both anti-apoptotic as well as capable of inhibiting Fas-L-mediated cytotoxicity of Fas-transfected P815 target cells. Thus, this study provides direct evidence of the likely biological means by which PGE(2) down-regulates T cell apoptosis.
引用
收藏
页码:2360 / 2365
页数:6
相关论文
共 49 条
[11]   Interferon α augments activation-induced T cell death by upregulation of Fas (CD95/APO-1) and Fas ligand expression [J].
Kaser, A ;
Nagata, S ;
Tilg, H .
CYTOKINE, 1999, 11 (10) :736-743
[12]   CD40 activation induces apoptosis in cultured human hepatocytes via induction of cell surface Fas ligand expression and amplifies Fas-mediated hepatocyte death during allograft rejection [J].
Afford, SC ;
Randhawa, S ;
Eliopoulos, AG ;
Hubscher, SG ;
Young, LS ;
Adams, DH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (02) :441-446
[13]   Glycyrrhizin inhibits TNF-induced, but not Fas-mediated, apoptosis in the human hepatoblastoma line HepG2 [J].
Yoshikawa, M ;
Toyohara, M ;
Ueda, S ;
Shiroi, A ;
Takeuchi, H ;
Nishiyama, T ;
Yamada, T ;
Fukui, H ;
Ishizaka, S .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1999, 22 (09) :951-955
[14]   Activation-induced T cell death: Resistance or susceptibility correlate with cell surface Fas ligand expression and T helper phenotype [J].
Oberg, HH ;
LenglJanssen, B ;
Kabelitz, D ;
Janssen, O .
CELLULAR IMMUNOLOGY, 1997, 181 (01) :93-100
[15]   Activation-induced apoptosis and cell surface expression of Fas (CD95) ligand are reciprocally regulated by retinoic acid receptor α and γ and involve nur77 in T cells [J].
Tóth, R ;
Szegezdi, É ;
Reichert, U ;
Bernardon, JM ;
Michel, S ;
Ancian, P ;
Kis-Tóth, K ;
Macsári, Z ;
Fésüs, L ;
Szondy, Z .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2001, 31 (05) :1382-1391
[16]   Resistance to Fas-mediated apoptosis is restored by cycloheximide through the downregulation of cellular FLIPL in NK/T-cell lymphoma [J].
Jeon, YK ;
Kim, H ;
Park, SO ;
Choi, HY ;
Kim, YA ;
Park, SS ;
Kim, JE ;
Kim, YN ;
Kim, CW .
LABORATORY INVESTIGATION, 2005, 85 (07) :874-884
[17]   Oxidative stress attenuates Fas-mediated apoptosis in Jurkat T cell line through Bfl-1 induction [J].
Kim, H ;
Kim, YN ;
Kim, H ;
Kim, CW .
ONCOGENE, 2005, 24 (07) :1252-1261
[18]   Transforming growth factor β1 inhibits Fas ligand expression and subsequent activation-induced cell death in T cells via downregulation of c-Myc [J].
Genestier, L ;
Kasibhatla, S ;
Brunner, K ;
Green, DR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (02) :231-239
[19]   FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients [J].
Cencioni, M. T. ;
Santini, S. ;
Ruocco, G. ;
Borsellino, G. ;
De Bardi, M. ;
Grasso, M. G. ;
Ruggieri, S. ;
Gasperini, C. ;
Centonze, D. ;
Barila, D. ;
Battistini, L. ;
Volpe, E. .
CELL DEATH & DISEASE, 2015, 6 :e1741-e1741
[20]   Oxidative stress attenuates Fas-mediated apoptosis in Jurkat T cell line through Bfl-1 induction [J].
Heejung Kim ;
Yong-Nyun Kim ;
Hyungsoo Kim ;
Chul-Woo Kim .
Oncogene, 2005, 24 :1252-1261